CMMB Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Chemomab Therapeutics Ltd (CMMB) is not a strong buy at the moment for a beginner investor with a long-term focus. The stock lacks positive momentum, has weak financial performance, and no significant catalysts or trading signals to indicate a compelling entry point. A hold is recommended until better opportunities arise.
The technical indicators are neutral. The MACD is slightly positive but contracting, RSI is neutral at 50.045, and moving averages are converging. The price is below the pivot level of 1.682, with support at 1.57 and resistance at 1.794. There is no strong trend or breakout signal.
NULL identified. No recent news or significant trading trends from hedge funds or insiders.
No recent news or positive sentiment to drive the stock higher.
In Q4 2025, revenue remained at 0 with no growth, net income dropped to -1,873,000 (-36.79% YoY), and EPS fell to 0 (-100% YoY). Gross margin remained at 0 with no improvement.
No data available on analyst ratings or price target changes.
